LOCALLY ADVANCED
Clinical trials for LOCALLY ADVANCED explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug enters first human trials for advanced tumors
Disease control Recruiting nowThis is the first study in people testing a new drug called AVZO-103 for advanced cancers that have spread. The main goals are to find a safe dose and see if the drug can shrink tumors in adults with advanced bladder cancer or other solid tumors. The study will test the drug alon…
Matched conditions: LOCALLY ADVANCED
Phase: PHASE1, PHASE2 • Sponsor: Avenzo Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 22:56 UTC
-
New pill tested for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new oral drug called REC-1245 for people with advanced cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug can help shrink tumors. Participants will take the pill daily for up to two years.
Matched conditions: LOCALLY ADVANCED
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Radioactive glue injection offers new hope for tough pancreatic tumors
Disease control Recruiting nowThis study is testing a new, one-time treatment for pancreatic cancer that cannot be removed by surgery. Doctors inject a radioactive 'glue' directly into the tumor to deliver targeted radiation, while patients continue their standard chemotherapy. The main goals are to see if th…
Matched conditions: LOCALLY ADVANCED
Phase: NA • Sponsor: BetaGlue Therapeutics SpA • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New Two-Drug combo aims to boost immune attack on lung cancer
Disease control Recruiting nowThis study is testing a personalized treatment approach for people with locally advanced non-small cell lung cancer (NSCLC). It combines a new two-drug immunotherapy regimen (cemiplimab and fianlimab) with targeted radiation therapy. The goal is to see if this combination can bet…
Matched conditions: LOCALLY ADVANCED
Phase: PHASE2 • Sponsor: Nitin Ohri • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Electric fields join radiation in fight against pancreatic cancer
Disease control Recruiting nowThis study is testing whether combining precise radiation therapy with a wearable device that creates electric fields around the tumor can slow the growth of locally advanced pancreatic cancer. All 48 participants will receive five days of targeted radiation while wearing the dev…
Matched conditions: LOCALLY ADVANCED
Phase: NA • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
App aims to catch cancer drug side effects faster
Disease control Recruiting nowThis study is testing whether a digital app that lets patients report their symptoms weekly helps doctors better manage side effects for people taking two cancer drugs (cabozantinib and nivolumab) for advanced kidney cancer. It involves 83 adults who are starting this specific dr…
Matched conditions: LOCALLY ADVANCED
Phase: PHASE4 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
First-of-its-Kind pill targets Cancer's 'Guardian Gene' mutation
Disease control Recruiting nowThis study is testing a new oral drug, PC14586 (rezatapopt), for people with advanced solid tumors that have a specific mutation in a gene called TP53 (Y220C). The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The trial is enrolling up…
Matched conditions: LOCALLY ADVANCED
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First patients receive experimental cancer drug in groundbreaking trial
Disease control Recruiting nowThis is the first human trial testing a new cancer drug called AVZO-1418. Researchers want to find the safest dose and see if it can shrink tumors in adults with advanced solid cancers that have spread or cannot be removed by surgery. The study will test the drug alone and possib…
Matched conditions: LOCALLY ADVANCED
Phase: PHASE1, PHASE2 • Sponsor: Avenzo Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New trial aims to zap lung cancer faster, with fewer side effects
Disease control Recruiting nowThis study is testing if a more precise, faster radiation treatment can better control advanced lung cancer that cannot be surgically removed. It will compare this new approach to the current standard method, both combined with chemotherapy and a year of immunotherapy. The main g…
Matched conditions: LOCALLY ADVANCED
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
New approach to lymph node surgery could reduce unnecessary procedures
Knowledge-focused Recruiting nowThis study is testing a more targeted approach to lymph node removal in patients with advanced breast cancer who have received chemotherapy before surgery. Researchers want to see if removing only specific marked lymph nodes (instead of many) can accurately determine whether canc…
Matched conditions: LOCALLY ADVANCED
Sponsor: Hospital Universitari de Bellvitge • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC